[1]刘 馨,王成中,李元明.益气活血解毒方治疗瘀毒互结型急性重症胰腺炎临床研究[J].陕西中医,2023,(10):1387-1390.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.011]
　LIU Xin,WANG Chengzhong,LI Yuanming.Yiqi Huoxue Jiedu formula in acute severe pancreatitis with the combination of blood stasis and poison[J].,2023,(10):1387-1390.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.011]
点击复制

益气活血解毒方治疗瘀毒互结型急性重症胰腺炎临床研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年10期
页码:
1387-1390
栏目:
临床研究
出版日期:
2023-10-05

文章信息/Info

Title:
Yiqi Huoxue Jiedu formula in acute severe pancreatitis with the combination of blood stasis and poison
作者:
刘 馨1; 王成中1; 李元明2
(1.恩施土家族苗族自治州中心医院重症医学科,湖北 恩施 445000; 2.北京医院肿瘤微创治疗中心,北京 100730)
Author(s):
LIU Xin; WANG Chengzhong; LI Yuanming
(Department of Intensive Care Medicine,Central Hospital of Enshi Tujia and Miao Autonomous Prefecture,Enshi 445000,China)
关键词:
急性重症胰腺炎;  瘀毒互结;  益气活血解毒方;  胃肠功能;  胰淀粉酶
Keywords:
Acute severe pancreatitis;  Blood stasis and toxin intertwined;  Yiqi Huoxue Jiedu formula;  Gastrointestinal function;  Pancreatic amylase
分类号:
R 657.51
DOI:
DOI:10.3969/j.issn.1000-7369.2023.10.011
文献标志码:
A
摘要:
目的:探究益气活血解毒方治疗瘀毒互结型急性重症胰腺炎的疗效。方法:将126例瘀毒互结型急性重症胰腺炎患者随机分为研究组和对照组,每组63例,对照组予以常规西医对症治疗,研究组在对照组基础上联合益气活血解毒方治疗。治疗7 d后,比较两组的中医症候、疗效、血清胰淀粉酶(PAMY)、脂肪酶(LPS)、胃动素(MTL)、胃泌素(GAS)、血管活性肠肽(VIP)、D-乳酸、二胺氧化酶(DAO)、内毒素、白细胞介素-10(IL-10)、单核细胞趋化因子蛋白-1(MCP-1)、核因子κB p65(NF-κB p65)水平,记录不良反应。结果:治疗后,两组患者的主症评分、次症评分均降低,研究组低于对照组(P<0.05)。研究组治疗总有效率高于对照组(P<0.05)。治疗后,两组患者的PAMY、LPS、GAS、D-乳酸、DAO、内毒素、MCP-1、NF-κB p65水平均低于治疗前,研究组低于对照组(P<0.05); MTL、VIP、IL-10水平均高于治疗前,研究组高于对照组(P<0.05)。两组患者均未出现严重不良反应。结论:益气活血解毒方治疗瘀毒互结型急性重症胰腺炎,可有效改善患者的胃肠道功能,抑制炎症反应,提升临床疗效。
Abstract:
Objective:To exploring the therapeutic effect of Yiqi Huoxue Jiedu formula on acute severe pancreatitis with blood stasis and toxin accumulation.Methods:A total of 126 cases of acute severe pancreatitis with the combination of blood stasis and toxin were randomly divided into a study group and a control group,with 63 cases in each group.The control group received routine western medicine symptomatic treatment,while the study group was treated with Yiqi Huoxue Jiedu formula on the basis of the control group.After 7 days of treatment,the TCM syndromes,efficacy,serum levels of pancreatic amylase(PAMY),lipase(LPS),motilin(MTL),Gastrin(GAS),vasoactive intestinal peptide(VIP),D-lactic acid,diamine oxidase(DAO),endotoxin,interleukin-10(IL-10),monocyte chemoattractant protein-1(MCP-1),and nuclear factor-κB p65(NF-κB p65)were compared between the two groups,and adverse reactions were recorded.Results:After treatment,the main and secondary syndrome scores of both groups of patients decreased,and the study group was lower than the control group(P<0.05).The effective rate of treatment in the research group was higher than that in the control group(P<0.05).After treatment,the levels of PAMY,LPS,GAS,D-lactate,DAO,endotoxin,MCP-1,and NF-κB p65 in both groups of patients were lower than before treatment,and the study group was lower than the control group(P<0.05).The levels of MTL,VIP,and IL-10 were all higher than before treatment,and the study group was higher than the control group(P<0.05).Both groups of patients did not experience serious adverse reactions.Conclusion:The Yiqi Huoxue Jiedu formula can effectively improve patients' gastrointestinal function,inhibit inflammatory reactions,and enhance clinical efficacy in the treatment of acute severe pancreatitis with the combination of blood stasis and toxin.

参考文献/References:

[1] 郝昱芳,安巧和.乌司他丁联合谷氨酰胺治疗急性重症胰腺炎对患者血清淀粉酶、前白蛋白和白蛋白的影响[J].陕西医学杂志,2020,49(10):1325-1328.
[2] Boxhoorn L,Voermans RP,Bouwense SA,et al.Acute pancreatitis[J].Lancet,2020,396(1):726-734.
[3] Heckler M,Hackert T,Hu K,et al.Severe acute pancreatitis:Surgical indications and treatment[J].Langenbecks Arch Surg,2021,406(3):521-535.
[4] 俞 洋,方 容.阶梯式微创疗法联合大黄牡丹汤保留灌肠治疗瘀毒互结型急性重症胰腺炎效果观察[J].现代中西医结合杂志,2023,32(1):88-92.
[5] 王 卫,戴佩佩,刘 皓,等.泻心汤合膈下逐瘀汤加减治疗急性胰腺炎(瘀毒互结证)的疗效观察[J].中国中医急症,2021,30(6):1056-1059.
[6] 余 萌,刘慧玲,王昊阳.醒胰汤保留灌肠联合西药治疗急性重症胰腺炎疗效及对患者血清淀粉酶和胃肠动力学的影响[J].陕西中医,2020,41(4):505-508.
[7] 谢彩杏,陈国忠,陈小霞,等.基于国家专利数据库分析中药复方治疗急性胰腺炎用药规律[J].国际中医中药杂志,2022,44(7):796-800.
[8] 师 帅,胡元会,吴华芹,等.“丹参-三七”药对作用机制的网络药理学探讨[J].中国实验方剂学杂志,2018,24(18):192-197.
[9] 杨闪闪,贾立群,郝少东.基于数据挖掘探索中成药复方治疗消化系统肿瘤的用药规律[J].海南医学院学报,2021,27(22):1716-1720.
[10] 中华医学会消化病学分会胰腺疾病学组,中华胰腺病杂志编辑委员会,中华消化杂志编辑委员会.中国急性胰腺炎诊治指南(2019年,沈阳)[J].中华消化杂志,2019,39(11):721-730.
[11] 国家食品药品监督管理总局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:383-385.
[12] 国家中医药管理局医政司.中医病症诊断疗效标准[M].南京:南京大学出版社,2017:67-68.
[13] Jablonska B,Mrowiec S.Nutritional support in patients with severe acute pancreatitis-current standards[J].Nutrients,2021,13(5):1498.
[14] Habtezion A,Gukovskaya AS,Pandol SJ.Acute pancreatitis:A multifaceted set of organelle and cellular interactions[J].Gastroenterology,2019,156(7):1941-1950.
[15] 姜 萌,赵 鹏.奥曲肽联合加贝酯治疗重症急性胰腺炎疗效及对患者血清细胞因子水平的影响[J].陕西医学杂志,2020,49(2):212-215.
[16] Olson E,Perelman A,Birk JW.Acute management of pancreatitis:The key to best outcomes[J].Postgrad Med J,2019,95(1124):328-333.
[17] 黄晓佩,秦秉玉,代荣钦,等.大黄逐瘀汤内服与灌肠治疗重症急性胰腺炎瘀毒互结证的临床疗效及对血清炎症因子的影响[J].中国实验方剂学杂志,2020,26(2):86-91.
[18] 肖 麟,徐 寅,周阳祥,等.扶正逐瘀泻火汤结合西医常规疗法治疗急性胰腺炎瘀毒互结证临床研究[J].国际中医中药杂志,2022,44(4):375-379.
[19] 黄 璟,姜 爽.消炎利胆汤联合乌司他丁治疗重症急性胰腺炎肝胆湿热证临床研究[J].陕西中医,2023,44(6):717-720,725.
[20] 秦松林,党 琳.“肺肠合治法”治疗急性胰腺炎探微[J].山东中医杂志,2018,37(4):274-276.
[21] 阮 玥,骆 霞,张晓燕,等.柴胡升气汤联合兰索拉唑对重症急性胰腺炎患者肠道黏膜屏障功能和炎症介质的影响[J].中国中医急症,2021,30(5):868-870.
[22] 李梦阁,党志博,张广玉,等.中药三联疗法联合西医常规治疗重症急性胰腺炎瘀毒互结证患者41例临床观察[J].中医杂志,2021,62(11):961-965.

相似文献/References:

[1]余 萌,刘慧玲,王昊阳.醒胰汤保留灌肠联合西药治疗急性重症胰腺炎疗效及对患者血清淀粉酶和胃肠动力学的影响*[J].陕西中医,2020,(4):505.
　YU Meng,LIU Huiling,WANG Haoyang..Curative effect of Xingyi decoction retention enema combined with western medicine on acute severe pancreatitis and their influences on serum amylase and gastrointestinal dynamics[J].,2020,(10):505.
[2]赵培西,许建秦,袁 彬,等.扶正抗癌方治疗肝癌肝郁脾虚瘀毒证临床研究[J].陕西中医,2022,(12):1746.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.022]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(91849132)
更新日期/Last Update: 2023-10-09